Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 449 followers

Latest posts

Last updated about 20 hours ago

Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation: 23/06/2025, Revision: 2, Status: Authorised

10 days ago

Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 35, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised

2 days ago

Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 13, Status: Authorised

about 22 hours ago

Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 11, Status: Authorised

about 22 hours ago

Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised

about 23 hours ago

Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation...

Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of authorisation: 22/12/2011, Revision: 8, Status: Withdrawn

about 23 hours ago

Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of...

Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 15, Status: Authorised

about 23 hours ago

Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised

about 23 hours ago

Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation...

Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive

1 day ago

Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive